TURN INNOVATION INTO IMPACT
Showcases of our success stories
Flagship case: Swedish Biotech PioneerBreaking a decade-long market barrier, we redefined the strategy, structure, and reach of one of Sweden’s leading biotech innovators, achieving multi-fold growth, new markets, OEM partnerships, and global scientific recognition.
|
Award-Winning Hearing Protection InnovationStarting as an independent development partner, we built the company’s most successful international operation, later becoming a stakeholder. Today, this award-winning Swedish innovation is a globally recognized market leader.
|
Gene Express Tech Licensing SuccessUnder a flexible independent consulting model, we delivered record-breaking results for a biotech innovator: the highest number of licensing agreements in a single year and the company’s first-ever commercial licensing deal.
|
TRANSFORMING A PIONEER INTO A MARKET LEADER
Dr. Chi was presented with a trophy for lecturing at A-Star conference in Singapore
MORE THAN A DECADE'S CHALLENGE
One of Sweden’s most reputable biotech companies, with roots in Pharmacia, has long been established in biomarker and assay development. Their precision assays have enabled groundbreaking discoveries for decades, forming the backbone of research in diabetes and other metabolic diseases.
Yet, despite their technological excellence, the company struggled for more than a decade to penetrate the Asia-Pacific market—a strategically extremely important one. Multiple approaches have been tried, including several attempts with internal consultants, and failed over a period of many years.
OUR HALLMARK CONSULTING SERVICE IN ACTION
Dr. Chi stepped in as Managing Director of Asia Pacific under our hallmark consulting model. This was not conventional consulting—it was an all‑in leadership role. What we brought to the table was a wealth of knowledge and the ability to turn insight into impact.
At the heart of our approach was a deep understanding of their innovation—not just the technology, but what it truly means for science and medicine. This insight made it possible to shape a distinctive value position and a compelling narrative that connected their assays to unmet needs in the marketplace. From that foundation came tailored scientific marketing messages that created resonance and credibility at the highest level.
Equally important is the depth of expertise we bring in deciphering the business and its environment as an interconnected whole. It is the ability to recognize, in one view, the structural limitations that hold growth back, the realities and constraints of each market, and at the same time the potential that lies beyond those boundaries. This comprehensive understanding makes it possible to see not only where value is being lost but also how new paths can be opened—how a technology can move beyond the confines of its internal limitation and find new channels, new segments, and new relevance. It is this integrative perspective, linking scientific insight with market realities and strategic vision, that allows a company trapped for years in the same position to break through and redefine its future.
ACTION TURN INTO ULTIMATE IMPACT
The impact was transformative.
The business moved from stagnation to sustained growth, achieving several‑fold expansion across the region and more than tenfold growth in key markets such as China. This growth was accompanied by a significant improvement in profitability and a strengthened financial foundation.
Strategic partnerships enabled automation of their technology, breaking through capacity limitations and opening new segments. At the same time, a dedicated collaboration in the clinical diagnostics field allowed the company to enter a completely new, much larger market that had previously been out of reach. These results elevated the company’s market position and brand recognition to a new level.
In parallel, scientific leadership was established through Dr. Chi’s presence as an invited speaker at major international conferences, giving the company a strong and lasting voice at the forefront of science.
As a direct result of this success, Dr. Chi’s mandate was extended beyond Asia-Pacific to become managing director of Asia and the Middle East.
One of Sweden’s most reputable biotech companies, with roots in Pharmacia, has long been established in biomarker and assay development. Their precision assays have enabled groundbreaking discoveries for decades, forming the backbone of research in diabetes and other metabolic diseases.
Yet, despite their technological excellence, the company struggled for more than a decade to penetrate the Asia-Pacific market—a strategically extremely important one. Multiple approaches have been tried, including several attempts with internal consultants, and failed over a period of many years.
OUR HALLMARK CONSULTING SERVICE IN ACTION
Dr. Chi stepped in as Managing Director of Asia Pacific under our hallmark consulting model. This was not conventional consulting—it was an all‑in leadership role. What we brought to the table was a wealth of knowledge and the ability to turn insight into impact.
At the heart of our approach was a deep understanding of their innovation—not just the technology, but what it truly means for science and medicine. This insight made it possible to shape a distinctive value position and a compelling narrative that connected their assays to unmet needs in the marketplace. From that foundation came tailored scientific marketing messages that created resonance and credibility at the highest level.
Equally important is the depth of expertise we bring in deciphering the business and its environment as an interconnected whole. It is the ability to recognize, in one view, the structural limitations that hold growth back, the realities and constraints of each market, and at the same time the potential that lies beyond those boundaries. This comprehensive understanding makes it possible to see not only where value is being lost but also how new paths can be opened—how a technology can move beyond the confines of its internal limitation and find new channels, new segments, and new relevance. It is this integrative perspective, linking scientific insight with market realities and strategic vision, that allows a company trapped for years in the same position to break through and redefine its future.
ACTION TURN INTO ULTIMATE IMPACT
The impact was transformative.
The business moved from stagnation to sustained growth, achieving several‑fold expansion across the region and more than tenfold growth in key markets such as China. This growth was accompanied by a significant improvement in profitability and a strengthened financial foundation.
Strategic partnerships enabled automation of their technology, breaking through capacity limitations and opening new segments. At the same time, a dedicated collaboration in the clinical diagnostics field allowed the company to enter a completely new, much larger market that had previously been out of reach. These results elevated the company’s market position and brand recognition to a new level.
In parallel, scientific leadership was established through Dr. Chi’s presence as an invited speaker at major international conferences, giving the company a strong and lasting voice at the forefront of science.
As a direct result of this success, Dr. Chi’s mandate was extended beyond Asia-Pacific to become managing director of Asia and the Middle East.
FLEXIBLE COLLABORATION FOR LICENSING SUCCESS
Licensing gene expression technology
A biotechnology company with a unique technology platform for enhancing protein expression in biopharmaceutical applications had world-class science but limited internal resources to commercialize its innovation.
Working under a flexible collaboration model, Channel Innometrics acted as an independent consultant responsible for driving licensing and business development in the Asian market. This structure allowed the company to leverage senior expertise and networks without the overhead of a permanent in-house team.
The results were remarkable: within less than a year, this collaboration delivered the highest number of licensing agreements ever achieved by the company in a single year and secured its first-ever commercial licensing deal – a milestone that significantly elevated its market position and commercial outlook.
Working under a flexible collaboration model, Channel Innometrics acted as an independent consultant responsible for driving licensing and business development in the Asian market. This structure allowed the company to leverage senior expertise and networks without the overhead of a permanent in-house team.
The results were remarkable: within less than a year, this collaboration delivered the highest number of licensing agreements ever achieved by the company in a single year and secured its first-ever commercial licensing deal – a milestone that significantly elevated its market position and commercial outlook.
FROM INDEPENDENT DEVELOPMENT TO STRATEGIC
PARTNERSHIP
Featured on Forbes
A young Swedish startup with an award-winning hearing protection innovation—recipient of the Gold Design Award in Sweden. With limited resources and expertise, the company began with a narrow focus on retail and general consumer markets such as pharmacies.
Recognizing the broader potential of this innovation, Channel Biomedix approached the company and entered into an independent development agreement. Under this model, we took full responsibility for developing a specific market as their independent distributor. Over the following decade, this collaboration became the company’s most successful international operation, expanding applications and achieving sustained growth.
On the strength of these results, the relationship evolved into a strategic partnership, with Channel becoming a stakeholder in the company to align long-term interests and innovation goals. Today, this hearing protection product is regarded as one of the best in the world, with international recognition and features in Forbes, The New York Times, Women’s Health, and National Geographic.
Recognizing the broader potential of this innovation, Channel Biomedix approached the company and entered into an independent development agreement. Under this model, we took full responsibility for developing a specific market as their independent distributor. Over the following decade, this collaboration became the company’s most successful international operation, expanding applications and achieving sustained growth.
On the strength of these results, the relationship evolved into a strategic partnership, with Channel becoming a stakeholder in the company to align long-term interests and innovation goals. Today, this hearing protection product is regarded as one of the best in the world, with international recognition and features in Forbes, The New York Times, Women’s Health, and National Geographic.